Marked Chart Marked Chart Closed · opens Mon 9:30 AM ET

The Marked Chart Wire · Business

Pharming

Pharming posts 21 percent revenue jump in third quarter, narrows 2026 outlook

Pharming reported third-quarter sales of $117.6 million, a 21 percent increase from last year, with operating costs at $74.6 million. The firm cut its 2026 revenue forecast to $380 million to $390 million and plans to finish its Napazimone trial enrollment by mid-2027.

Illustration for the Business desk

More Business news

Fast headlines, summarized. Not verified and not advice. Check the full story before you act.